NCT04961996, A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physicianʼs Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer) - ClinicalTrials.gov
Accessed October 17, 2021 at: